Gaia Fertility Moved From VC Share Classes to One Parent Shareholder

Gaia Fertility Ltd's UK register now shows one legal shareholder where its 2024 filings showed a venture-style stack of ordinary, non-voting ordinary, Seed and Series A shares. A confirmation statement filed on 9 October 2026 records 920,689 ordinary shares, all held by GAIA FAMILY INC.

That is a clear legal consolidation. It is not yet a clear economic exit. The public filings do not say whether the former holders were bought out, exchanged into a parent, rolled into another instrument or settled through a wider group reorganisation. The latest record therefore changes the visible rights structure without disclosing the price or mechanism behind the change.

The distinction matters because founder and shareholder records now point to different surfaces. Nader Alsalim remains an active person with significant control and a current director entry, while Gaia Family Inc is the sole ordinary shareholder. The Companies House record establishes the two facts separately. It does not show that Alsalim owns the parent's shares or explain how the investor preference stack disappeared.

The latest statement is a one-class, one-holder state

The latest Companies House confirmation statement, dated 9 September 2026 and filed on 9 October, reports one class of ordinary shares. Each share carries full voting, dividend and capital-distribution rights, with no redemption right. The shareholder section names Gaia Family Inc for all 920,689 shares.

The Companies House company profile identifies GAIA FERTILITY LIMITED as an active company incorporated on 21 May 2019. Its latest confirmation date is 9 September 2026. The legal state is therefore recent and specific: a single ordinary class at the confirmation date, not a prediction about what a later allotment or group filing might show.

The contrast with the earlier filings is the useful signal:

The totals are not a perfect denominator across the dates. The 2023 correction and the 2024 allotment describe different filing states, and the 2024 statement has a detailed shareholder list that should be read with its capital statement rather than used to manufacture a fully diluted cap table. The robust conclusion is the change in classes and named holder, not a claim about a precise percentage sold by every earlier investor.

The 2024 record exposed a venture-style preference stack

The 2024 CS01 names Nader Alsalim with 500,000 ordinary shares. It also lists Atomico V SCSP with 170,881 Series A shares, Avcap Investments Luxembourg with 11,361 ordinary shares, Kindred Capital II across Seed and Series A holdings, Seedcamp IV, Optum Venture Global Partners, Clocktower Technologies II, GA Fund I, KCP Nominees on behalf of investors in Tiny EIS Fund, Tiny Fund II, Next Round Ventures, Scout VI-A and other named people and vehicles.

The 2024 SH01 records a 17 July allotment of 448 non-voting ordinary shares for £978.30 cash. Its statement of capital lists 511,361 ordinary shares, 8,261 non-voting ordinary shares, 173,827 Seed shares and 227,689 Series A shares. The different classes carry different rights. The filing text gives ordinary shares voting and distribution rights, while the non-voting class is excluded from general-meeting voting and appears alongside the preferred distribution provisions.

That matters commercially. In a downside or exit, a preference layer can rank ahead of ordinary economics. The public documents do not disclose each investor's preference amount, conversion election, consent rights or payout outcome. They do show that the earlier register was not a flat pool of identical ordinary shares. The 2026 CS01 removes that visible class-by-class hierarchy from the company-level shareholder list, but does not tell us whether the economic rights were paid, exchanged or preserved elsewhere.

The 2023 correction adds historical context. It restates a 9 December 2022 allotment of 11,361 ordinary shares for £0.0001 and a 920,690-share capital state. Comparing that number with the 920,689 in the 2026 CS01 is useful as a warning against mechanical arithmetic: the one-share difference does not identify a transfer, cancellation or consideration. It simply shows why the dated documents must be read on their own terms.

Gaia Family Inc and Nader Alsalim are different register surfaces

Gaia's UK site describes Gaia Fertility Ltd as the trading company and Gaia Family Inc as an affiliate or parent brand. That public framing is consistent with the Companies House result naming the US corporation as the shareholder, but it does not fill in the transaction history.

The control record is separate from the share register. A PSC04 filed for Nader Alsalim records a 24 February 2026 change in which he has the right to exercise, or actually exercises, significant influence or control over Gaia Fertility Ltd. The Companies House PSC page is the current public index for that control surface. It does not say that Alsalim holds the ordinary shares now named to Gaia Family Inc.

The distinction is familiar in parent and operating-company structures. Restate's parent-versus-opco filing story shows why a funding or ownership headline can sit at one legal level while operating-company filings show another. Gaia's current statement goes further on the shareholder line, but the PSC filing keeps a founder-control question visible. Neither document should be flattened into a single ownership percentage.

The separate UK company GAIA FAMILY LIMITED, company number 13885271, is not the same entity as the US GAIA FAMILY INC named in the 2026 CS01. The UK company is a dormant subsidiary in the public register. Treating its existence as proof of the US parent's shareholder identity would confuse two legal entities.

The register shows consolidation, not the transaction price

There are several possible explanations for the reset. Former investors may have exchanged their interests for shares in Gaia Family Inc or another parent. They may have been settled in cash. The group may have reorganised the rights stack before a later financing or sale. A filing delay could also mean that another document has not yet appeared. These are hypotheses, not findings from the current record.

What can be said firmly is narrower. The 2026 confirmation statement reports Gaia Family Inc as the sole ordinary shareholder of Gaia Fertility Ltd. It does not identify consideration, the direction of any transfer, a buyout price, the treatment of liquidation preferences, or the reason Nader Alsalim remains an active PSC. Funding Spotter's filing-based report provides useful independent coverage of the sole-shareholder event and the named historical investors, but it also does not supply the missing instrument or price.

For an investor, lender or counterparty, the practical question is not whether Gaia's cap table was “cleaned up.” It is which rights moved to the parent, which rights ended, and which rights remain contractually outstanding outside the UK company's shareholder list. The public filing has answered the first legal question, but not those economic ones.

The next document to watch

The next decisive evidence would be a later SH01 or CS01, a subscription or reorganisation document, updated accounts, or a parent-level filing that identifies the issuing entity and the treatment of the former holders. A new PSC change could also clarify whether the founder's influence rights were preserved, narrowed or replaced.

Until then, Gaia Fertility should be described as a company whose UK register moved from a multi-class venture cap table to one ordinary shareholder, Gaia Family Inc, while Nader Alsalim remains visible as an active PSC and director. The legal consolidation is source-backed. The price, mechanism and investor outcome remain open.

For researchers maintaining a repeatable evidence trail, the UK Companies House source guide explains how to keep shareholder, PSC and filing-date surfaces separate. That separation is the difference between a verifiable control change and an invented transaction story.